跳至主要内容
临床试验/NCT07212751
NCT07212751进行中(未招募)不适用

Coronary CT Angiogram - Prognostic Value of Adverse Plaque Features in Guiding Treatment (CT-PLAQUE)

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 22,000 人开始时间: 2020年1月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
22,000
试验地点
1
主要终点
Nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death and all-cause death

研究概览

简要总结

The study aims at determining if the presence of adverse plaque features identified from the CT angiogram can help determine prognosis and guide treatment options.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient who is ≥ 18 years old presented with chest pain and has undergone CTA between 01-Jan-2012 and 31-Dec-2022 before treatment
  • •If multiple CTAs are taken, the most updated one before treatment commencement will be chosen.

排除标准

  • •Patient who did not undergo cardiac CT scan due to inability to undergo cardiac CT scanning, kidney failure (serum creatinine >250 μmol/L or estimated glomerular filtration rate <30 mL/min), major allergy to contrast.

研究组 & 干预措施

Patient who is ≥ 18 years old presented with chest pain and has undergone CTA before treatment

干预措施: CTCA (Diagnostic Test)

结局指标

主要结局

Nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death and all-cause death

时间窗: 5 years after CTCA examinations

次要结局

  • Total plaque (mm³) to predict cardiac events(5 years after CTCA examinations)
  • Calcified plaque (mm³) to predict cardiac events(5 years after CTCA examinations)
  • Non-calcified plaque (mm³) to predict cardiac events(5 years after CTCA examinations)
  • CT-FFR to predict cardiac events(5 years after CTCA examinations)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验